A Non-Interventional Long-term Safety Study of Ruxolitinib in Myelofibrosis
Latest Information Update: 15 Jun 2016
At a glance
- Drugs Ruxolitinib (Primary)
- Indications Myelofibrosis
- Focus Adverse reactions
- 18 Apr 2015 Status changed from recruiting to active, no longer recruiting as reported by United Kingdom Clinical Research Network record.
- 11 Sep 2013 New trial record